Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Nintedanib-[13C,d3] is the labelled analogue of Nintedanib. Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). Group: Pharmaceutical. Alternative Names: Nintedanib 13CD3; [13C,2H3]-BIBF 1120; [13C,2H3]-Intedanib; [13C,2H3]-Vargatef; methyl (Z)-3-(((4-(N-methyl-2-(4-(methyl-13C-d3)piperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; Ofev-13C,d3. Pack Sizes: 5 mg. Product ID: BLP-006061. Molecular formula: C30[13C]H30D3N5O4. Mole weight: 543.65. Custom synthesis is available. Send your inquiries for more information.
Nintedanib esylate is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β. Uses: The treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. Alternative Names: Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino) (phenyl)methylidene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ethanesulfonate; BIBF1120; BIBF 1120 BIBF-1120; Nintedanib esylate Nintedanib ethanesulfonate salt; Intedanib; Brand name OFEV Vargatef. CAS No. 656247-18-6. Pack Sizes: 500 mg. Product ID: B0084-434827. Molecular formula: C33H39N5O7S. Mole weight: 649.76. Custom synthesis is available. Send your inquiries for more information.
London
Nintedanib Impurity 6 (Intedanib Impurity 6)
BIBF 1202 is the major in-vivo metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR. It is a related compound of Intedanib, which is an indolinone derivative that inhibits angiokinase and an antitumor agent. It is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (VEGF) signaling pathway thus inhibition of tumor angiogenesis. Uses: Bibf 1202 is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (vegf) signaling pathway thus inhibition of tumor angiogenesis. Group: Pharmaceutical. Alternative Names: BIBF-1202; BIBF 1202; BIBF1202. (3Z)-2,3-Dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid;(Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1 -yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylic acid;Nintedanib Impurity 5. CAS No. 894783-71-2. Pack Sizes: 50 mg. Product ID: B0084-474893. Molecular formula: C30H31N5O4. Mole weight: 525.6. Custom synthesis is available. Send your inquiries for more information.
London
Nintedanib Impurity D
An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. Alternative Names: (3Z)?-2,?3-Dihydro-3-[[[4-(methylamino)?phenyl]?amino]?phenylmethylene]?-2-oxo-1H-Indole-6-carboxylic Acid Methyl Ester. CAS No. 1987887-92-2. Pack Sizes: 100 mg. Product ID: B1421-478184. Molecular formula: C24H21N3O3. Mole weight: 399.45. Custom synthesis is available. Send your inquiries for more information.
London
Nintedanib (Intedanib)
Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). Group: Pharmaceutical. Alternative Names: Vargatef; BIBF-1120; BIBF 1120; BIBF1120; Intedanib. CAS No. 656247-17-5. Pack Sizes: 500 mg. Product ID: B0084-262244. Molecular formula: C31H33N5O4. Mole weight: 539.62. Custom synthesis is available. Send your inquiries for more information.
An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. Alternative Names: Nintedanib Impurity 50. CAS No. 2410284-90-9. Pack Sizes: 1 mg. Product ID: B2694-478193. Molecular formula: C56H52N8O8. Mole weight: 965.08. Custom synthesis is available. Send your inquiries for more information.
An impurity of Nintedanib, which is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/66 nM. Group: Pharmaceutical. Alternative Names: 1160293-25-3; methyl 1-(2-chloroacetyl)-2-oxoindoline-6-carboxylate1-(2-chloroacetyl)-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl estermethyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate1H-Indole-6-carboxylic acid, 1-(2-chloroacetyl)-2,3-dihydro-2-oxo-, methyl ester. CAS No. 1160293-25-3. Pack Sizes: 100 mg. Product ID: B2694-338804. Molecular formula: C12H10ClNO4. Mole weight: 267.66. Custom synthesis is available. Send your inquiries for more information.
London
Methyl 1-Acetyl-2-oxoindoline-6-carboxylate
An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. Alternative Names: 1-acetyl-2-oxo-3H-indole-6-carboxylic acid methyl ester; methyl 1-acetyl-2-oxo-3H-indole-6-carboxylate. CAS No. 676326-36-6. Pack Sizes: 100 mg. Product ID: B1421-184191. Molecular formula: C12H11NO4. Mole weight: 233.22. Custom synthesis is available. Send your inquiries for more information.
An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. Alternative Names: N-methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide; N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide. CAS No. 1139453-98-7. Pack Sizes: 100 mg. Product ID: B1421-258623. Molecular formula: C14H20N4O3. Mole weight: 292.33. Custom synthesis is available. Send your inquiries for more information.
An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. Alternative Names: N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide; 1038972-16-5; CS-0011633; N-Methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide (Nintedanib Impurity). CAS No. 1038972-16-5. Pack Sizes: 100 mg. Product ID: B1421-284921. Molecular formula: C13H18N4O3. Mole weight: 278.31. Custom synthesis is available. Send your inquiries for more information.
An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 2037385-84-3. Pack Sizes: 100 mg. Product ID: B1421-284922. Molecular formula: C13H19ClN4O3. Mole weight: 314.77. Custom synthesis is available. Send your inquiries for more information.
London
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.